Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch
Source: SeekingAlpha
2026-02-04 20:57:16 ET
...
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
-0.23% G/L:
$4.25 Last:
165,588 Volume:
$4.24 Open:
ACHV Latest News
March 04, 2026 08:00:00 am
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
January 12, 2026 08:47:00 am
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
